The Right Partner for Early Phase Oncology

A significant percentage of PPD’s oncology business over the last five years has been driven by the delivery of more than 200 Phase I and II oncology studies conducted in all major early phase clinical research regions around the globe. Our extensive Phase I experience across a diverse range of malignancies and investigational products provides PPD with a strong foundation for partnering with biotech or pharma to develop innovative biologics or small molecule investigational products.

PPD has access to a network of oncology sites with broad capabilities in terms of early stage experience and clinical pharmacology expertise. At the same time, PPD targets countries and sites with robust Phase I capabilities in oncology to build collaborative partnerships to deliver future trial programs.